rewirebio.iobenchmarks
Contested result

Nucleotide Transformer and RNAErnie: Benchmarking pre-trained genomic language models for RNA sequence-related predictive applications and RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md disagree

  • Low severity
  • Not yet reviewed
  • two-study-conflict
  • unknown

Benchmarking pre-trained genomic language models for RNA sequence-related predictive applications ranks Nucleotide Transformer above RNAErnie in 7 of 7 comparisons; RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md ranks RNAErnie above Nucleotide Transformer in 4 of 4 comparisons. No other study gives a verdict, so neither is the outlier.

An automatic lead, not a finding of error. The results below are shown as published, everywhere on the site, until a reviewer decides otherwise.

Which studies agree

2 papers rank Nucleotide Transformer above RNAErnie in 7 of their 19 comparisons and RNAErnie higher in 4; 8 are ties. Of those papers, RNAGym fitness leaderboard ranks RNAErnie higher on its own (4 of 4).

Papers grouped by which system they rank higher: Nucleotide Transformer or RNAErnieRank Nucleotide Transformer higher: Benchmarking pre-trained genomic…. Rank RNAErnie higher: RNAGym fitness leaderboard. Mixed: none.Rank Nucleotide Transformer h…MixedRank RNAErnie higherBenchmarkingpre-trained genomic…Benchmarking pre-trained genomic language models for RNA sequence-related predictive applicationsRNAGym fitness leaderboardRNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md
  • Rank Nucleotide Transformer higher (1): Benchmarking pre-trained genomic…
  • Rank RNAErnie higher (1): RNAGym fitness leaderboard
  • Mixed (0): none

Each paper sits where at least two thirds of its comparisons point; Mixed means neither model reaches two thirds. The larger, outlined dot is the paper that disagrees.

Comparisons in which each paper scores Nucleotide Transformer or RNAErnie higherBenchmarking pre-trained genomic…: Nucleotide Transformer higher in 7, RNAErnie higher in 0, 8 ties. RNAGym fitness leaderboard: Nucleotide Transformer higher in 0, RNAErnie higher in 4, 0 ties.Benchmarking pre-trained genomic…Benchmarking pre-trained genomic language models for RNA sequence-related predictive applications7 Nucleotide Transformer higher78 tie8RNAGym fitness leaderboardRNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md4 RNAErnie higher4
Nucleotide Transformer higherTieRNAErnie higherNumbers are counts of comparisons; the outlined bar is the paper that disagrees.
Papers compared (2)
PaperRoleRanks Nucleotide Transformer higherRanks RNAErnie higherTies
Benchmarking pre-trained genomic language models for RNA sequence-related predictive applications and 1 more record · DOIAgrees708
RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md · RepositoryAgrees040
Comparisons in Benchmarking pre-trained genomic… (15)
ProtocolDatasetMetricNucleotide TransformerRNAErnieHigher
GTEx tissue-specific splicing prediction, Splice acceptors and donors (You et al. 2026 Supplementary Table 5)GTEx-derived tissue-specific splice site usage dataset (You et al. 2026)AUPRC (GTEx splicing task, Splice acceptors and donors, averaged over categories), fraction0.8830.806Nucleotide Transformer
GTEx tissue-specific splicing prediction, Splice-15class (You et al. 2026 Supplementary Table 5)GTEx-derived tissue-specific splice site usage dataset (You et al. 2026)AUPRC (GTEx splicing task, Splice-15class, averaged over categories), fraction0.8650.687Nucleotide Transformer
GTEx tissue-specific splicing prediction, Splice-53class (You et al. 2026 Supplementary Table 5)GTEx-derived tissue-specific splice site usage dataset (You et al. 2026)AUPRC (GTEx splicing task, Splice-53class, averaged over categories), fraction0.8630.685Nucleotide Transformer
NT-splice-sites-acceptors splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, acceptorsAccuracy (NT-splice-sites-acceptors, fine-tuned), fraction0.990.979Nucleotide Transformer
NT-splice-sites-acceptors splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, acceptorsF1 (NT-splice-sites-acceptors, fine-tuned), fraction0.990.979Nucleotide Transformer
NT-splice-sites-acceptors splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, acceptorsPrecision (NT-splice-sites-acceptors, fine-tuned), fraction0.990.979Nucleotide Transformer
NT-splice-sites-acceptors splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, acceptorsRecall (NT-splice-sites-acceptors, fine-tuned), fraction0.990.979Nucleotide Transformer
NT-splice-sites-all splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, all sitesAccuracy (NT-splice-sites-all, fine-tuned), fraction0.9840.981Tie
NT-splice-sites-all splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, all sitesF1 (NT-splice-sites-all, fine-tuned), fraction0.9840.981Tie
NT-splice-sites-all splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, all sitesPrecision (NT-splice-sites-all, fine-tuned), fraction0.9840.981Tie
NT-splice-sites-all splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, all sitesRecall (NT-splice-sites-all, fine-tuned), fraction0.9840.981Tie
NT-splice-sites-donors splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, donorsAccuracy (NT-splice-sites-donors, fine-tuned), fraction0.9910.983Tie
NT-splice-sites-donors splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, donorsF1 (NT-splice-sites-donors, fine-tuned), fraction0.9910.983Tie
NT-splice-sites-donors splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, donorsPrecision (NT-splice-sites-donors, fine-tuned), fraction0.9910.983Tie
NT-splice-sites-donors splice-site classification, fine-tuned models (You et al. 2026 Supplementary Table 4)Nucleotide Transformer benchmark splice-site dataset, donorsRecall (NT-splice-sites-donors, fine-tuned), fraction0.9910.983Tie
Comparisons in RNAGym fitness leaderboard (4)
ProtocolDatasetMetricNucleotide TransformerRNAErnieHigher
RNAGym v0.1.1 fitness, signed Spearman, AptamerRNAGym Aptamer DMS assays (2)Spearman (mean signed Spearman over the 2 Aptamer assays), unitless-0.08860.0306RNAErnie
RNAGym v0.1.1 fitness, signed Spearman, macro over 3 ncRNA categoriesRNAGym ncRNA DMS assays (31)Spearman (macro-mean over 3 ncRNA categories (equal category weights)), unitless0.120.194RNAErnie
RNAGym v0.1.1 fitness, signed Spearman, RibozymeRNAGym Ribozyme DMS assays (26)Spearman (mean signed Spearman over the 26 Ribozyme assays), unitless0.1330.134RNAErnie
RNAGym v0.1.1 fitness, signed Spearman, tRNARNAGym tRNA DMS assays (3)Spearman (mean signed Spearman over the 3 tRNA assays), unitless0.3170.416RNAErnie

What disagrees

studies
2
Compared
Nucleotide Transformer, RNAErnie
Study that disagrees
Other studies
Rule
two-study-conflict; unknown
Model identity
Matched across studies partly through links not yet reviewed

Follow-up

Current state: Not yet reviewed.

No one has reviewed this finding yet.

How to help resolve this

If you know why these studies disagree, for example a different population, metric or preprocessing step, or you have a corrected value, tell us through the contribution form. A reviewer checks every submission against its source before anything changes, and the step is added to the follow-up above.

Finding discrepancy-175128b829e1b42e · All contested results · How findings are made and followed up